Mineralocorticoid receptor antagonists offer an alternative for nonresolving CSC

• Posted on: Mar 25 2019
• By: Saratoga Opthalmology
• Leave a response

This retrospective interventional case series examines the benefit of mineralocorticoid receptor antagonists (MRA) in patients with persistent central serous chorioretinopathy (CSC).
Source: AAO

Posted in: Uncategorized